Advantages of histamine H4 receptor antagonist usage with H1 receptor antagonist for the treatment of murine allergic contact dermatitis

Experimental Dermatology

Volumn 21, Issue 9, 2012, Pages 714-715

  Matsushita, Ayuko ^a   Seike, Masahiro ^a   Okawa, Haruka ^a   Kadawaki, Yayoi ^a   Ohtsu, Hiroshi ^b  

^a SAGAMI WOMEN'S UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Chronic allergic contact dermatitis; H1 receptor antagonist; H4 receptor antagonist

Indexed keywords

1 (5 CHLORO 2 INDOLYLCARBONYL) 4 METHYLPIPERAZINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; OLOPATADINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; EOSINOPHIL COUNT; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; LETTER; MAST CELL; MONOTHERAPY; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; SKIN ALLERGY;

ANIMALS; DERMATITIS, ALLERGIC CONTACT; DIBENZOXEPINS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FEMALE; HISTAMINE H1 ANTAGONISTS; IMMUNOGLOBULIN E; INDOLES; INTERLEUKIN-4; INTERLEUKIN-5; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; PICRYL CHLORIDE; PIPERAZINES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE;

EID: 84865316898     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2012.01559.x     Document Type: Letter

References (18)

1. Kitagaki H, Fujisawa S, Watanabe K et al. J Invest Dermatol 1995: 105: 749-755.
2. Kitagaki H, Ono N, Hayakawa K et al. J Immunol 1997: 159: 2484-2491.
3. Seike M, Ikeda M, Kodama H et al. Exp Dermatol 2005: 14: 169-175.
4. Weise C, Zhu Y, Ernst D et al. Exp Dermatol 2011: 20: 805-809.
5. Röse L, Schneider C, Stock C et al. Exp Dermatol 2011: 21: 25-31.
6. Seike M, Takata T, Ikeda M et al. Arch Dermatol Res 2005: 297: 68-74.
7. Hamada R, Seike M, Kamijima R et al. Eur J Pharmacol 2006: 547: 45-51.
8. Seike M, Furuya K, Omura M et al. Allergy 2010: 65: 319-326.
9. Thurmond R L, Gelfand E W, Dunford P J. Nat Rev Drug Discov 2008: 7: 41-53.
10. Dunford P J, Williams K N, Desai P J et al. J Allergy Clin Immunol 2007: 119: 176-183.
11. Venable J D, Thurmond R L. Antiinflamm Antiallergy Agents Med Chem 2006: 5: 307-322.
12. Seifert R, Schneider E H, Dove S et al. Mol Pharmacol 2011: 79: 631-638.
13. Ling P, Ngo K, Nguyen S et al. Br J Pharmacol 2004: 142: 161-171.
14. Hofstra C L, Desai P J, Thurmond R L et al. J Pharmacol Exp Ther 2003: 305: 1212-1221.
15. Deml K F, Beermann S, Neumann D et al. Mol Pharmacol 2009: 76: 1019-1030.
16. Hamid Q, Boguniewicz M, Leung D Y. J Clin Invest 1994: 94: 870-876.
17. Coruzzi G, Pozzoli C, Adami M et al. Exp Dermatol 2012: 21: 32-37.
18. Cameron G S, Pence B C. J Invest Dermatol 1992: 99: 189-192.